ea0063p324 | Reproductive Endocrinology 1 | ECE2019
Sansone Andrea
, Sansone Massimiliano
, Selleri Raffaella
, Seraceno Silvia
, Scipione Valeria
, Sellasie Sium Wolde
, Schiavo Anna
, Lenzi Andrea
, Romanelli Francesco
Background: Many testosterone (T) formulations are now available for treating male hypogonadism. Intramuscular injectable T esters and transdermal T gel are the most commonly used in clinical practice. Transdermal T gel is often preferred by patients due to ease of use and reduced fluctuations in serum T compared to injectable esters. A daily dosage of 20 mg 80 mg mimicking circadian profile is recommended to adequately treat hypogonadal men.Aim: ...